Equinoxe Humeral Augmented Tray: 1st Shoulder Surgeries with New Solution for Proximal Humeral Bone Loss Performed in Florida

March 29, 2021

The Equinoxe Humeral Augmented Tray is the first implant of its kind. It replaces the greater tuberosity, a part of the shoulder that may be absent or deficient, fractured and/or reabsorbed due to disease.

The HAT was designed to be used in combination with the Equinoxe Platform Shoulder System for reverse procedures and was designed to help improve joint mechanics and stability for patients with proximal humeral bone loss. This unique implant can also be used with an extension for more severe proximal bone loss cases.

The first surgeries with the Humeral Augmented Tray were performed last week in Florida by Bradley Schoch, MD, of the Mayo Clinic in Jacksonville, and design team surgeon Howard Routman, DO, of JFK Medical Center in Lantana.

“The patients who need this implant have either previously undergone surgeries which failed, suffered fractures of the humeral head, or have congenital abnormalities that leave them with deficient tuberosities, which prevent them from doing what they want,” said Dr. Routman. “This implant allows them to return to what they love, and I feel very honored to have been part of the design team and one of the first to use this prosthesis.”

“We are very pleased to launch the Humeral Augmented Tray and excited to receive feedback from our surgeon colleagues and see its impact on patients. Its addition to the Equinoxe Shoulder family allows us to reach even more patients,” said Vice President of Extremities Chris Roche.

The design team includes Dr. Routman, Thomas Wright, MD, of the University of Florida in Gainesville, Fla.; Pierre-Henri Flurin, MD, of Surgical Clinic of Bordeaux in Merginac, France; Matthew Hansen, MD, of Banner Gateway Medical Center in Gilbert, Ariz.; Raymond Klug, MD, of Lakewood Regional Medical Center in Lakewood, Calif.; and Joseph D. Zuckerman, MD, of NYU Langone Orthopedic Hospital in New York City.

 

SourceExactech
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version